Oxytocin restores context-specific hyperaltruistic preference
Figures

Experimental design and task.
(A) Experimental task. Subjects performed a money-pain trade-off task in which they were designated as deciders. Four conditions (gain-self, gain-other, loss-self, loss-other) were introduced across decision contexts (gain vs. loss) and shock-recipients (self vs. other). Prior to the task, subjects received a neutral description of monetary values and potential shocks associated with choices options (see Figure 1—figure supplement 1 for details). In each trial, subjects were asked to choose between two options with various amounts of monetary and harm consequences. The chosen option was highlighted for 1 s after subjects’ decisions. (B) Procedures of the oxytocin study (study 2). Before the task, a pain calibration procedure was performed on each subject to determine their pain thresholds for electrical shock stimuli. Subjects were then administered with 24 IU oxytocin nasal spray or placebo (saline). Then, 35 min later, subjects commenced the money-pain trade-off task. Finally, they filled out questionnaires including post-task surveys and assessments of personality traits.

Experimental instructions provided to subjects.
Choice options were provided to subjects in a neutral and descriptive manner, with the focus on the relevant components (shocks and money) across four conditions.

Context-specific hyperaltruistic preferences.
(A) Subjects chose less painful options more frequently for others than for themselves in the gain context, demonstrating a hyperaltruistic preference. However, this tendency was absent in the loss context. (B) The harm aversion parameter κ for others was significantly greater than that of self in the gain context but not in the loss context (also see the ‘Materials and methods’ section and Figure 2—figure supplement 2 for the harm aversion model analysis and model comparison results). (C) Furthermore, a mixed-effect logistic regression analysis showed that the relative harm sensitivity, calculated as the difference of regression coefficients of in the other- and self-conditions (), was significant in the gain context, but not in the loss context (also see Figure 2—figure supplement 1 for details). (D) However, the relative money sensitivity, the difference of regression coefficients of in the other- and self-conditions (), did not show contextual specificity. Error bars represent SE across subjects (n=80). NS, not significant; ** and *** .

Mixed-effect logistic regression analysis results for study 1 (regression model 1).
∆m and ∆s represent the objective differences in money and electric shocks between the more and less painful options. and are numerical variables, while the context (gain vs. loss) and recipient (other vs. self) are categorical variables. The interaction was further elucidated in Figure 2C and D. Con: context; Rec: recipient. Error bars represent 95% confidence interval (CI). NS, not significant, * , ** , and *** .

Model comparison results.
To investigate whether the choice consistency parameter (γ) was condition specific, four candidate models were compared: (M1) γ was constant across all conditions; (M2) γ varied based on the pain recipient (self vs. other); (M3) γ varied between decision contexts (gain vs. loss); and (M4) γ varied across all four conditions (self-gain, other-gain, self-loss, and other-loss). Model 1 (M1) performed the best among all the four candidate models both in Study 1 (A) and Study 2 (B).

Individual difference in moral preferences.
Hyperaltruism () was negatively associated with instrumental harm (IH) attitudes (A) but not with impartial beneficence (IB) attitudes (B). (C) The correlation between IH and subjects’ relative harm sensitivities () was marginally different between the gain and loss contexts (also see Figure 3—figure supplement 2A). (D) However, no significant associations were observed between subjects’ relative monetary sensitivities () and IH or IB (see Figure 3—figure supplement 2B). Please note that since both IH and IB were correlated with empathic concern (EC) scores (see Figure 3—figure supplement 1), the multiple regression analysis was conducted with EC included as a covariate of no interest. The regression coefficients in (A, C, D) show the relationship between IH and moral behavior, controlling for EC and IB, while the coefficient in (B) shows the relationship between IB and moral preference, controlling for EC and IH. NS, not significant.

The relationship between empathic concern (EC) and utilitarian moral personality traits.
Correlation between EC and hyperaltruism (), instrumental harm (IH), impartial beneficence (IB) both in study 1 (A–C) and study 2 (D-F). All the correlations were performed using Pearson correlations.

Association between impartial beneficence (IB) and subjects’ relative harm/money sensitivities in Study 1.
IB showed no significant correlation with subjects’ relative harm sensitivities () (A) or relative monetary sensitivities () (B). The regression coefficients showed the association between IB and relative harm/monetary sensitivities, controlling for empathic concern (EC) and instrumental harm (IH).

Oxytocin significantly promoted hyperaltruistic preference in the loss context.
(A) In contrast to the placebo condition, oxytocin administration restored hyperaltruistic behavior in the loss decision context. (B) Model-based hyperaltruistic parameter () showed similar patterns: hyperaltruistic tendency was reduced in the loss context of the placebo session but restored in the oxytocin session (also see Figure 4—figure supplements 1 and 2 for the influence of oxytocin on the persoanlity triats and the relationship between hyperaltruistic preference and these moral personality triats). Error bars represent SE across subjects (n=46). NS, not significant; * , ** , and *** .

Oxytocin did not influence personality traits in study 2.
(A–C) Oxytocin did not affect subjects’ ratings on empathic concern (EC), instrumental harm (IH), or impartial beneficence (IB). Error bars represent SE. NS, not significant.

Relationships between hyperaltruism and utilitarian moral personality traits in study 2.
(A–B) In the placebo session, hyperaltruistic preferences () showed a marginally negative correlation with instrumental harm (IH) but no significant correlation with impartial beneficence (IB). (C, D) In the oxytocin session, hyperaltruistic preferences exhibited significantly negative correlation with IH and IB. The regression coefficients in (A, C) show the relationship between IH and moral preference, controlling for empathic concern (EC) and IB, while the coefficient in (B, D) shows the relationship between IB and moral preference, controlling for EC and IH.

Oxytocin effect on relative harm/ money sensitivities.
(A, B) The effect of oxytocin on relative harm/ money sensitivity was assessed via the mixed-effect logistic regression analysis (regression model 2). Oxytocin significantly modulated the context-specificity of relative harm sensitivity (), while having no effect on the contextual differences of the relative monetary sensitivities () (also see Figure 5—figure supplements 1 and 2 for detailed results of the regression analysis). (C) The decision context modulated the correlation between instrumental harm (IH) and subjects’ harm sensitivities in the placebo session. (D) The modulation effect of decision context was absent in the oxytocin session (also see Figure 5—figure supplement 3 for the oxytocin’s effect on the association between relative monetary sensitivities and IH). Error bars represent SE across subjects. The regression coefficients in (C, D) showed the association between IH and relative harm sensitivities, controlling for empathic concern and impartial beneficence. NS, not significant; * , ** .

The main results of mixed-effect logistic regression analysis in study 2 (regression model 2).
∆m and ∆s represent the objective differences in money and electric shocks between the more and less painful options. The interaction was further explained in Figure 5, Figure 5—figure supplement 2. The interaction was further explained in Figure 5B. Treat.: treatment (placebo vs. oxytocin); Con.: decision contexts (gain vs. loss), and Rec.: recipient (self vs. other) are all categorical variables. Error bars represent 95% confidence interval (CI). NS, not significant, * and *** .

Pain sensitivity across experimental conditions.
The administration of oxytocin significantly reduced participants’ pain sensitivities yet also restored the pain sensitivity patterns in both the gain and loss conditions relative to the placebo session. Error bars represent SE across subjects. NS, not significant, * and *** .

Associations between relative harm/money sensitivities and utilitarian moral personality traits in study 2.
(A, D) The relative monetary sensitivities () were not significantly related with instrumental harm (IH) in either the placebo or oxytocin session. (B, E) In both the placebo and oxytocin sessions, there was no significant correlation between relative harm sensitivity () and impartial beneficence (IB). (C, F) No significant correlation was found between relative monetary sensitivities and IB in either the placebo or oxytocin sessions. (A, D) illustrates the relationship between IH and relative monetary sensitivities, with empathic concern (EC) and IB controlled. (B, C, E, F) described the relationship between IB and relative harm/monetary sensitivities, controlling for EC and IH.

Oxytocin modulated the contextual influence on hyperaltruistic behaviors.
(A) The non-parametric Friedman tests showed that monetary loss (relative to gain) significantly reduced subjects’ perception of harm framing in the task. Oxytocin augmented harm framing perception, particularly in the loss context, effectively removing the contextual specificity of harm framing perception. (B) The conceptual diagram of the moderated mediation model. We assume that the perceived harm framing mediates the relationship between instrumental harm and relative harm sensitivity, with decision context moderating the mediation effect. (C) The moderating effect of decision context was significant under placebo condition. However, oxytocin obliterated the contextual moderation effect by reinstating the mediating role of harm perception in the loss context. Error bars represent SE across subjects. NS, not significant; * , ** .
Tables
Contribution of empathic concern (EC), instrumental harm (IH), and impartial beneficence (IB) scores on subjects’ behavior in study 1.
The table presents results from three multiple regression analyses. The dependent variables in the three analyses were hyperaltruism (), relative harm sensitivity (), and relative monetary sensitivity (). Results in bold are further illustrated in Figure 3C.
Predictors | Hyperaltruism | Relative harm sensitivity | Relative monetary sensitivity | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β | SE | t | P | β | SE | t | P | β | SE | t | P | |
Intercept | –0.086 | 0.153 | –0.563 | 0.574 | –0.086 | 0.162 | –0.532 | 0.596 | 0.121 | 0.147 | 0.825 | 0.411 |
EC | 0.011 | 0.006 | 2.080 | 0.039 | 0.012 | 0.006 | 2.063 | 0.041 | 0.004 | 0.005 | 0.738 | 0.461 |
IH | –0.039 | 0.015 | –2.501 | 0.013 | –0.053 | 0.016 | –3.224 | 0.002 | –0.022 | 0.015 | –1.476 | 0.142 |
IB | 0.009 | 0.022 | 0.421 | 0.675 | 0.019 | 0.023 | 0.804 | 0.423 | –0.008 | 0.021 | –0.369 | 0.713 |
Context (gain vs. loss) | –0.163 | 0.217 | –0.754 | 0.452 | –0.298 | 0.229 | –1.302 | 0.195 | 0.058 | 0.208 | 0.280 | 0.780 |
EC × context | 0.002 | 0.008 | 0.216 | 0.829 | 0.003 | 0.008 | 0.383 | 0.702 | –0.004 | 0.007 | –0.484 | 0.629 |
IH × context | 0.016 | 0.022 | 0.726 | 0.469 | 0.045 | 0.023 | 1.959 | 0.052 | –0.001 | 0.021 | –0.034 | 0.973 |
IB × context | –0.004 | 0.031 | –0.115 | 0.908 | –0.009 | 0.033 | –0.268 | 0.789 | –0.001 | 0.030 | –0.032 | 0.974 |
Contribution of empathic concern (EC), instrumental harm (IH), and impartial beneficence (IB) scores on participants’ behavior in study 2.
Tables 2a (placebo session) and 2b (oxytocin session) show the results of three multiple regression analyses. The dependent variables in the three analyses were hyperaltruism (κother – κself), relative harm sensitivity (otherβΔs – selfβΔs), and relative monetary sensitivity (otherβΔm – selfβΔm). Results in bold are further illustrated in Figure 5C and D.
a. Placebo condition | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Predictors | Hyperaltruism | Relative harm sensitivity | Relative monetary sensitivity | |||||||||
β | SE | t | P | β | SE | t | P | β | SE | t | P | |
Intercept | –0.085 | 0.123 | –0.688 | 0.493 | 0.065 | 0.17 | 0.382 | 0.704 | –0.205 | 0.266 | –0.771 | 0.443 |
EC | 0.005 | 0.004 | 1.162 | 0.248 | 0.006 | 0.006 | 1.086 | 0.281 | –0.004 | 0.009 | –0.444 | 0.658 |
IH | –0.032 | 0.017 | –1.904 | 0.06 | –0.071 | 0.024 | –3.005 | 0.003 | 0.035 | 0.037 | 0.967 | 0.336 |
IB | 0.047 | 0.021 | 2.2 | 0.031 | 0.029 | 0.029 | 1 | 0.32 | 0.086 | 0.046 | 1.887 | 0.063 |
Context (gain vs. loss) | –0.034 | 0.174 | –0.197 | 0.844 | –0.34 | 0.241 | –1.412 | 0.162 | 0.323 | 0.375 | 0.862 | 0.391 |
EC × context | 0.002 | 0.006 | 0.332 | 0.74 | 0.005 | 0.008 | 0.601 | 0.549 | 0.003 | 0.012 | 0.264 | 0.792 |
IH × context | 0.018 | 0.024 | 0.737 | 0.463 | 0.077 | 0.033 | 2.297 | 0.024 | –0.062 | 0.052 | –1.187 | 0.238 |
IB × context | –0.051 | 0.03 | –1.711 | 0.091 | –0.047 | 0.042 | –1.14 | 0.257 | –0.084 | 0.065 | –1.295 | 0.199 |
b. Oxytocin condition | ||||||||||||
Intercept | 0.138 | 0.125 | 1.1 | 0.275 | 0.056 | 0.109 | 0.511 | 0.611 | 0.049 | 0.253 | 0.195 | 0.846 |
EC | 0.01 | 0.004 | 2.397 | 0.019 | 0.006 | 0.004 | 1.675 | 0.098 | 0.001 | 0.009 | 0.157 | 0.876 |
IH | –0.047 | 0.017 | –2.721 | 0.008 | –0.037 | 0.015 | –2.458 | 0.016 | 0.053 | 0.035 | 1.541 | 0.126 |
IB | –0.034 | 0.019 | –1.813 | 0.073 | –0.009 | 0.016 | –0.582 | 0.562 | –0.041 | 0.038 | –1.091 | 0.279 |
Context (gain vs. loss) | –0.071 | 0.177 | –0.401 | 0.69 | 0.092 | 0.154 | 0.596 | 0.553 | –0.372 | 0.358 | –1.04 | 0.301 |
EC × context | 0.002 | 0.006 | 0.385 | 0.701 | –0.002 | 0.005 | –0.336 | 0.737 | 0.012 | 0.012 | 0.985 | 0.327 |
IH × context | 0.008 | 0.024 | 0.323 | 0.747 | –0.006 | 0.021 | –0.272 | 0.786 | –0.045 | 0.049 | –0.918 | 0.361 |
IB × context | –0.01 | 0.026 | –0.384 | 0.702 | –0.012 | 0.023 | –0.526 | 0.6 | 0.024 | 0.053 | 0.457 | 0.649 |
Moderated mediation analysis results for study 2.
In the moderated mediation model, IH serves as the independent variable, harm framing report as the mediator, relative harm sensitivity as the dependent variable, and decision context (gain vs. loss) as the moderator. Coefficient a represents the influence of the independent variable on the mediator, while coefficient b represents the effect of the mediator on the dependent variable, and coefficient c’ represents the direct effect (insignificant c’ suggests a full mediation effect). The coefficients in bold indicate the moderation effect of the context (gain vs. loss) in both the placebo and oxytocin sessions ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001.
Predictors | Placebo | Oxytocin | ||
---|---|---|---|---|
Mediator | Dependent variable | Mediator | Dependent variable | |
Harm framing report β (SE) | Relative harm sensitivity β (SE) | Harm framing report β (SE) | Relative harm sensitivity β (SE) | |
Intercept | 1.196 (0.279) *** | 0.069 (0.023) ** | 1.609 (0.239) *** | 0.049 (0.014) *** |
Context (gain vs. loss) | –0.739 (0.396) | –0108 (0.032) ** | –0.196 (0.338) | –0.002 (0.019) |
Empathic concern (EC) | 0.020 (0.046) | 0.008 (0.004) * | 0.023 (0.040) | 0.005 (0.002) * |
Impartial beneficence (IB) | –0.116 (0.239) | 0.010 (0.019) | –0.270 (0.179) | –0.008 (0.010) |
Instrumental harm (IH) | –0.758 (0.257) *** a | –0.018 (0.016) c’ | –0.753 (0.220) *** a | –0.017 (0.011) c’ |
Context × IH | 0.784 (0.343) * | – | –0.137 (0.291) | – |
Harm framing report | – | 0.039 (0.008) *** b | – | 0.028 (0.006) *** b |